In its 6th year, ISR’s “CRO Quality Benchmarking – Phase II/III Service Providers (2014)” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied satisfaction ratings from 474 service encounters across 29 Phase II/III CROs, making this report the most comprehensive assessment of CRO service quality in the industry. For more information: http://www.isrreports.com/product/cro-quality-benchmarking-phase-iiiii-service-providers-2014/

1. QUALITY
CRO
BENCHMARKING
PHASE II/III
CRO Quality
Benchmarking –
Phase II/III Service
Providers (2014)
Info@ISRreports.com
©2014 Industry Standard Research www.ISRreports.com
PREVIEW

2. www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 2
act with confidence
Report Overview
In its 6th year, ISR’s “CRO Quality Benchmarking – Phase II/III Service Providers (2014)” report provides
pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality.
Respondents supplied satisfaction ratings from 474 service encounters across 29 Phase II/III CROs,
making this report the most comprehensive assessment of CRO service quality in the industry.
273Charts and Graphs
148Respondents
152Pages
474Service Encounters 1. Outsourcing Behaviors, Attitudes, Beliefs, and Intentions
• Phase II/III Leaders
• Proposal Volume
• Service Provider Usage
• Service Provider Preference
• Service Provider Cost Perceptions
2. Service Provider Selection Drivers
• Most Important Service Provider Attributes
• Service Provider Attributes Gaining Importance
3. Service Provider Performance and Scorecards Across Attributes
• “Staff Characteristics” Ratings
• “Operational Excellence” Ratings
• “Organizational & Finance” Ratings
4. Service Provider Service Quality Profiles
How you can use this report:
Study Sponsors
• Make a more informed purchase of Phase II/
III services by understanding which service
providers best fit your company’s needs
• Broaden your Phase II/III CRO evaluation list
by accessing peer-based service quality ratings
across 25 critical attributes
• Pinpoint potential delivery concerns early in a
sponsor-CRO relationship/ evaluation in order
to develop proactive strategies to address
potential gaps
Clinical Service Providers
• Uncover your own — and competitor —
delivery strengths and weaknesses
• Design messaging to tout your company’s
strengths
• Compete more effectively by understanding
buyers’ selection criteria and outsourcing
trends
NEXT: Companies Included
Report Structure:

3. www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 3
act with confidence
Service Quality Metrics
Staff Characteristics
• Commercial market knowledge
• CRA quality
• Staff turnover
• Project manager quality
• Project team chemistry
• Responsiveness
• Therapeutic expertise
• Timely project communications
Organization & Finance Characteristics
• Breadth of services
• Financial strength / stability
• Global footprint
• Low cost
• Minimizing change orders
Operational Excellence
• Data quality
• Local Market / Regulatory Knowledge
• Meeting database lock timelines
• Meeting first patient / first visit
timelines
• Meeting overall project timelines
• Network of sites/ investigators
• Offered innovative solutions
• Patient recruitment strategy
• Speed of site/ investigator
recruitment
• Speed of site start-up
• Technology for real-time access to
data
• Up-front contingency planning and
trial risk management
CROs Included in this Report
• Accenture
• Aptiv Solutions
• BioClinica
• Charles River Laboratories
• Chiltern
• Clinical Research Services
(CRS)
• Clinipace
• Clinsys
• Cognizant
• Covance
• DCRI – Duke
• Encorium
• Eurofins
• Frontage
• HungaroTrial
• ICON
• INC Research
• inVentiv Health Clinical
• Medpace
• PAREXEL
• PPD
• PRA
• Premier Research
• Quintiles
• Rho
• SGS Life Sciences
• Tata
• Theorem
• Worldwide Clinical Trials
9% C-level
12% President/ VP
52% Director
24% Manager
3% Other
Participant Job Title Participant Geography Participant Company Size
55%
North
America
34%
Europe
Asia/
Other
11%
55% Large Companies
(R&D $1B or more)
23% Mid-Size
Companies (R&D
$100M-$999M)
22% Small Companies
(R&D less than $100M)
Report Metrics
Respondent Demographics (N=148)
Participant Experience: Mean = 16 years

4. www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 4
act with confidence
Table of Contents
For full table of contents and additional sample pages, download the full preview from
our website: http://www.isrreports.com/product/cro-quality-benchmarking-phase-
iiiii-service-providers-2014/

5. www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 5
act with confidence
act with confidence
Introduction
www.ISRreports.com ©2014 | CRO Quality Benchmarking Phase II/III Service Providers (2014) 7
Introduction
Welcome to ISR’s 2014 CRO Quality Benchmarking Phase II/III report� This report
marks the sixth edition of this study and, though the study design is revisited and
refreshed each year to account for evolution within the industry, the impetus for per-
forming this research remains the same� Over time, Industry Standard Research has
accumulated a wealth of knowledge around service quality and CRO performance�
Understanding and utilizing this information allows stakeholders within the industry
to make informed decisions when choosing a CRO for Phase II/III services�
ISR knows that selecting a CRO isn’t easy� There is a myriad of factors to evaluate for
each CRO being considered� Does the provider have the necessary therapeutic ex-
pertise? Will the trial be completed on time and within budget? Will the provider be
able to successfully recruit patients? Are the project managers of high caliber? With-
out prior experience with a provider, purchasers of CRO services are often forced to
rely on incomplete or biased assessments of CRO performance passed on through
word of mouth from peers within the industry�
In the CRO Quality Benchmarking Phase II/III report, ISR provides the data necessary
to answer these questions – and many more – with confidence� 148 decision-
makers have weighed in with their CRO selection criteria and outsourcing behaviors�
They have provided feedback on 474 recent service encounters across 29 Phase II/
III CROs� 16 providers have received detailed profiles, eight large CROs and eight
mid-size/specialty CROs� Find out in which areas large CROs dominate and in which
performance areas the smaller CROs shine�
Not only does this report enable more educated purchases of CRO services, it also
allows providers to get a behind-the-scenes look at customers’ perceptions of their
performance� Providers can determine areas of strength and understand where they
may need to close the gap relative to competitors� As they say, knowledge is power�
Having a grasp on customer perceptions of strengths and weaknesses will help CROs
effectively promote their strengths and improve areas in which they are falling short�
Sample Page

6. www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 6
act with confidence
Sample Page
act with confidence
Service Provider Performance and Scorecards Across Attributes
www.ISRreports.com ©2014 | CRO Quality Benchmarking Phase II/III Service Providers (2014) 26
For sponsors and service providers – use these Consumer Reports-style summary charts to quickly
ascertain the strengths and weaknesses of the service providers profiled in this report.
Company A
Company B
Company C
Company D
Company E
Company F
Company G
Company H
Company I
Company J
Company K
Company L
Company M
Company N
Company O
Company P
Respon-
sivenessCRA Quality
Project
manager
quality
Staff
turnover
Project team
chemistry
Therapeutic
expertise
Commercial
Market
Knowledge
Staff Characteristics
©2014 Industry Standard Research
Ratings Key: Clear leadership Better than most About average Falling a bit short
Timely project
communications
©2014 Industry Standard Research

7. www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 7
act with confidence
Sample Page
For full table of contents and additional sample pages, download the full preview from
our website: http://www.isrreports.com/product/cro-quality-benchmarking-phase-
iiiii-service-providers-2014/

8. www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 8
act with confidence
Ordering Information
Industry Standard Research (ISR) is the premier, full service market research provider to the pharma and pharma services indus-
tries. With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise.
For more information about our off-the-shelf intelligence and custom research offerings, please visit our Web site at
www.ISRreports.com, email info@ISRreports.com, or follow us on twitter @ISRreports.
About Industry Standard Research
For pricing and ordering information, please visit our website: http://www.isrreports.
com/product/cro-quality-benchmarking-phase-iiiii-service-providers-2014/

9. www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase II/III Service Providers (2014) 9
act with confidence
www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 9
act with confidence
www.ISRreports.com ©2014 | Preview of: Benchmarking European Investigator Payments 10
act with confidence
www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10
act with confidence
The ISR Difference
Custom-quality syndicated market research
www.ISRreports.com
ISR's Reports
The Common
Syndicated Reportvs.
How confident are you?
vs.
DataCollection
ISR's proprietary data collection
tools and channels support fast,
high quality data collection
Struggle to recruit the right
targets and enough of them
vs.
SampleSizes
Robust sample sizes that
instill confidence
Often insufficient industry
representation that leaves you
defending results
vs.vs.
Research methods
Mostly primary
research;
always appropriate
for the topic
One size fits all;
usually publically
available data
vs.vs.
Respondents
Sophisticated screening
ensures genuine
decision-makers
Undisclosed
methodologies and
respondent demographics
vs.vs.
Analysts
Decades of experience
means more insights that are
immediately usable
Junior analysts capable of
reporting numbers